Copyright Reports & Markets. All rights reserved.

Global Drugs for Ophthalmology Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Drugs for Ophthalmology Market Overview

      • 1.1 Product Overview and Scope of Drugs for Ophthalmology
      • 1.2 Drugs for Ophthalmology Segment by Type
        • 1.2.1 Global Drugs for Ophthalmology Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Gels
        • 1.2.3 Eye Solutions
        • 1.2.4 Capsules & Tablets
        • 1.2.5 Eye Drops
        • 1.2.6 Ointments
      • 1.3 Drugs for Ophthalmology Segment by Application
        • 1.3.1 Drugs for Ophthalmology Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Retail Pharmacy
      • 1.4 Global Drugs for Ophthalmology Market by Region
        • 1.4.1 Global Drugs for Ophthalmology Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Drugs for Ophthalmology Market Size
        • 1.5.1 Global Drugs for Ophthalmology Revenue (2014-2025)
        • 1.5.2 Global Drugs for Ophthalmology Production (2014-2025)

      2 Global Drugs for Ophthalmology Market Competition by Manufacturers

      • 2.1 Global Drugs for Ophthalmology Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Drugs for Ophthalmology Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Drugs for Ophthalmology Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Drugs for Ophthalmology Production Sites, Area Served, Product Types
      • 2.5 Drugs for Ophthalmology Market Competitive Situation and Trends
        • 2.5.1 Drugs for Ophthalmology Market Concentration Rate
        • 2.5.2 Drugs for Ophthalmology Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Drugs for Ophthalmology Production Market Share by Regions

      • 3.1 Global Drugs for Ophthalmology Production Market Share by Regions
      • 3.2 Global Drugs for Ophthalmology Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Drugs for Ophthalmology Production
        • 3.4.1 North America Drugs for Ophthalmology Production Growth Rate (2014-2019)
        • 3.4.2 North America Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Drugs for Ophthalmology Production
        • 3.5.1 Europe Drugs for Ophthalmology Production Growth Rate (2014-2019)
        • 3.5.2 Europe Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Drugs for Ophthalmology Production (2014-2019)
        • 3.6.1 China Drugs for Ophthalmology Production Growth Rate (2014-2019)
        • 3.6.2 China Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Drugs for Ophthalmology Production (2014-2019)
        • 3.7.1 Japan Drugs for Ophthalmology Production Growth Rate (2014-2019)
        • 3.7.2 Japan Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Drugs for Ophthalmology Consumption by Regions

      • 4.1 Global Drugs for Ophthalmology Consumption by Regions
      • 4.2 North America Drugs for Ophthalmology Consumption (2014-2019)
      • 4.3 Europe Drugs for Ophthalmology Consumption (2014-2019)
      • 4.4 China Drugs for Ophthalmology Consumption (2014-2019)
      • 4.5 Japan Drugs for Ophthalmology Consumption (2014-2019)

      5 Global Drugs for Ophthalmology Production, Revenue, Price Trend by Type

      • 5.1 Global Drugs for Ophthalmology Production Market Share by Type (2014-2019)
      • 5.2 Global Drugs for Ophthalmology Revenue Market Share by Type (2014-2019)
      • 5.3 Global Drugs for Ophthalmology Price by Type (2014-2019)
      • 5.4 Global Drugs for Ophthalmology Production Growth by Type (2014-2019)

      6 Global Drugs for Ophthalmology Market Analysis by Applications

      • 6.1 Global Drugs for Ophthalmology Consumption Market Share by Application (2014-2019)
      • 6.2 Global Drugs for Ophthalmology Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Drugs for Ophthalmology Business

      • 7.1 Allergan
        • 7.1.1 Allergan Drugs for Ophthalmology Production Sites and Area Served
        • 7.1.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.1.3 Allergan Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Aerie Pharmaceuticals
        • 7.2.1 Aerie Pharmaceuticals Drugs for Ophthalmology Production Sites and Area Served
        • 7.2.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.2.3 Aerie Pharmaceuticals Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Pfizer
        • 7.3.1 Pfizer Drugs for Ophthalmology Production Sites and Area Served
        • 7.3.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.3.3 Pfizer Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Valeant
        • 7.4.1 Valeant Drugs for Ophthalmology Production Sites and Area Served
        • 7.4.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.4.3 Valeant Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Bayer
        • 7.5.1 Bayer Drugs for Ophthalmology Production Sites and Area Served
        • 7.5.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.5.3 Bayer Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Genentech
        • 7.6.1 Genentech Drugs for Ophthalmology Production Sites and Area Served
        • 7.6.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.6.3 Genentech Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Novartis
        • 7.7.1 Novartis Drugs for Ophthalmology Production Sites and Area Served
        • 7.7.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.7.3 Novartis Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Regeneron
        • 7.8.1 Regeneron Drugs for Ophthalmology Production Sites and Area Served
        • 7.8.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.8.3 Regeneron Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Shire
        • 7.9.1 Shire Drugs for Ophthalmology Production Sites and Area Served
        • 7.9.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.9.3 Shire Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Santen Pharmaceutical
        • 7.10.1 Santen Pharmaceutical Drugs for Ophthalmology Production Sites and Area Served
        • 7.10.2 Drugs for Ophthalmology Product Introduction, Application and Specification
        • 7.10.3 Santen Pharmaceutical Drugs for Ophthalmology Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Drugs for Ophthalmology Manufacturing Cost Analysis

      • 8.1 Drugs for Ophthalmology Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Drugs for Ophthalmology
      • 8.4 Drugs for Ophthalmology Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Drugs for Ophthalmology Distributors List
      • 9.3 Drugs for Ophthalmology Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Drugs for Ophthalmology Market Forecast

      • 11.1 Global Drugs for Ophthalmology Production, Revenue Forecast
        • 11.1.1 Global Drugs for Ophthalmology Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Drugs for Ophthalmology Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Drugs for Ophthalmology Price and Trend Forecast (2019-2025)
      • 11.2 Global Drugs for Ophthalmology Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Drugs for Ophthalmology Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Drugs for Ophthalmology Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Drugs for Ophthalmology Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Drugs for Ophthalmology Production, Revenue Forecast (2019-2025)
      • 11.3 Global Drugs for Ophthalmology Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Drugs for Ophthalmology Consumption Forecast (2019-2025)
        • 11.3.2 Europe Drugs for Ophthalmology Consumption Forecast (2019-2025)
        • 11.3.3 China Drugs for Ophthalmology Consumption Forecast (2019-2025)
        • 11.3.4 Japan Drugs for Ophthalmology Consumption Forecast (2019-2025)
      • 11.4 Global Drugs for Ophthalmology Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Drugs for Ophthalmology Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Drugs for ophthalmology, which are used to treat eye conditions and eye diseases such as glaucoma, conjunctivitis and others.

        The global Drugs for Ophthalmology market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Drugs for Ophthalmology volume and value at global level, regional level and company level. From a global perspective, this report represents overall Drugs for Ophthalmology market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Allergan
        Aerie Pharmaceuticals
        Pfizer
        Valeant 
        Bayer
        Genentech
        Novartis
        Regeneron
        Shire
        Santen Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Gels
        Eye Solutions
        Capsules & Tablets
        Eye Drops
        Ointments

        Segment by Application
        Hospital
        Retail Pharmacy

        Buy now